about
Differential MR delayed enhancement patterns of chronic myocardial infarction between extracellular and intravascular contrast mediaPathological mechanism for delayed hyperenhancement of chronic scarred myocardium in contrast agent enhanced magnetic resonance imaging.High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodelingTemporal dystrophic remodeling within the intrinsic cardiac nervous system of the streptozotocin-induced diabetic rat modelSuccessful cardiac resuscitation with extracorporeal membrane oxygenation in the setting of persistent ventricular fibrillation: a case report.Collateral circulation formation determines the characteristic profiles of contrast-enhanced MRI in the infarcted myocardium of pigs.Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart.Unanticipated intra-operative finding of pulmonary artery tumour thromboembolism during radical nephrectomy and caval thrombectomy: Case report and management.FIASCO II failure to achieve a satisfactory cardiac outcome study: the elimination of system errors.Assessment of three techniques for delivering stem cells to the heart using PET and MR imaging.Hibernating myocardium: pathophysiology, diagnosis, and treatment.Death in low-risk cardiac surgery: the failure to achieve a satisfactory cardiac outcome (FIASCO) study.Rat model of veno-arterial extracorporeal membrane oxygenation.Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.What are the predictors that affect the excellent long-term benefits of redo coronary artery bypass grafting?Successful ablation of idiopathic left ventricular tachycardia in an adult patient during extracorporeal membrane oxygenation treatment.Functional mitral regurgitation: current understanding and approach to management.Autophagy and heart disease: implications for cardiac ischemia-reperfusion damage.Resuscitative extracorporeal membrane oxygenation for in hospital cardiac arrest: a Canadian observational experience.Type A aortic dissection complicated by an aorto-right atrial fistula.Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing.Canada's longest experience with extracorporeal membrane oxygenation as a bridge to lung transplantation: a case report.Ex vivo perfusion of the swine heart as a method for pre-transplant assessment.Donor heart preservation: straight up, or on the rocks?Extracorporeal membrane oxygenation for blastomycosis-related acute respiratory distress syndrome: a case series.Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes.Laparoscopic nephroureterectomy in a patient with a left ventricular assist device.Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death?The effect of total spinal anesthesia on cardiac function in a large animal model of brain death.Adult presentation with a bilobed membranous ventricular septal aneurysm.Stentless aortic valve replacement in patients with bicuspid aortic valve disease: clinical outcome and aortic diameter changes during follow-up.Simultaneous Salmonella spp. endocarditis and mycotic abdominal aortic aneurysm presentation: a surgical dilemma.A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death.The acutely occluded left main coronary artery culprit in cardiogenic shock and initial percutaneous coronary intervention: a substudy of the Manitoba "no option" left main PCI registry.Can long-term ventricular assist devices be safely implanted in low-volume, non-heart transplant centres?K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts.Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.Assessment of donor heart viability during ex vivo heart perfusion.A whole blood-based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion.Activation of proteolytic enzymes and depression of the sarcolemmal Na+/K+-ATPase in ischemia-reperfused heart may be mediated through oxidative stress.
P50
Q27311032-38ACE0A6-6DF7-4622-8FCD-197ACF9D9BB6Q30815396-4005C7D6-8F1C-411F-A79D-53B21A8801A4Q31161236-B53509BD-A27D-4A50-8E9D-7AD7DCCD0AACQ34501103-C09DB8CE-2FD8-4C2F-82A9-36DEC562D9A0Q34537591-97969256-E92B-41A9-8E19-91C1F00A4E0BQ35289460-730B6DE4-B8BC-4FF8-A8F9-A4A5525AAA7BQ36049332-4EFBE910-E9EC-4905-80FF-C78203130B87Q36889447-AF76557E-9E53-4866-ADE6-090841AFBEE7Q36939904-7509DDE7-1306-4C9B-9ABB-47A74E84DB71Q37283846-56A0786E-DB08-4DC3-8CFE-DCDDF072981BQ37445512-3C1E7B93-84B9-4AE4-BDE3-9938BEF6823CQ37551341-FE7207C9-4B48-45BC-B245-1E405864F8DAQ37587486-C45EB10C-5AA8-438E-AE00-F18F8B620A41Q37734257-1807BAAF-1EA7-4B6E-998C-0E8140F46310Q37736915-F9528B19-108C-4B05-AE0C-16A3A5A14EECQ38165442-6319002F-DB4B-4490-938B-BA8DF0050BBAQ38181717-C5CA70B9-50B9-43DA-B25B-0D646DD78DF1Q38217383-51FCFCF5-E33A-4A7D-8936-1FEAFB65082FQ38275533-DF8575B3-8032-45A9-BE25-C7161B911D2AQ38302305-B3E71BBD-E6C6-460C-B5AC-C842126BE35FQ38518685-2DC4DB72-6272-45FF-8633-3453A81EBEEAQ39043923-958A06AA-5D78-496E-8CBF-B68B68D1BD57Q39603297-573CD7BA-1B1E-460C-834B-F616BECB0F52Q41049662-535CAFD5-166E-417F-BC79-DF0BF6A20E40Q41349350-CF893CF1-D7CE-4334-9766-49CE3F0CA0C1Q41726971-A0F49858-BABA-453B-B2B4-B302BC7C42FAQ41861430-9B76E380-CBCC-40F6-84D0-921485A31C42Q42971502-4B222C67-7454-47FE-88B1-D47320C3DEB6Q43875224-B89BB572-EC68-459E-8619-B4AE46785D7DQ43928730-6014973D-A55F-48AC-8968-F2F3251067F1Q44756889-9330C2FF-4334-4037-BAF7-AE831BCA3F0CQ45000353-867EF841-14B2-4596-A84E-A11E3B20EA2DQ45143737-8E67D62B-91AF-4796-90E3-FFCE2A6C5E78Q45265558-33252147-23E8-4B13-9A56-154889D43AE3Q46099404-96D8CB99-F10A-457A-801D-66177D8E25D1Q46954153-B86E6545-B88C-42D3-9DA3-5700DD7998EAQ47410087-93F8B3CE-DE97-4FFA-93CA-7F19DDAA41B9Q47658845-99724BB7-0861-412D-9072-764A28656DCCQ47782043-9D541C58-7A39-4C89-BAD8-C2A7460D668FQ48735973-3504B4DA-8133-4E5E-B5D9-B4F5839081F3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Darren Freed
@ast
Darren Freed
@en
Darren Freed
@es
Darren Freed
@nl
Darren Freed
@sl
type
label
Darren Freed
@ast
Darren Freed
@en
Darren Freed
@es
Darren Freed
@nl
Darren Freed
@sl
prefLabel
Darren Freed
@ast
Darren Freed
@en
Darren Freed
@es
Darren Freed
@nl
Darren Freed
@sl
P106
P1153
7103219209
P21
P31
P496
0000-0002-6239-1444
P569
2000-01-01T00:00:00Z